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Abstract
Background: To protect from erosion of the tube in glaucoma drainage device (GDD), the tube is covered by a
biologic tissue which is roofed by the conjunctiva. Sclera, pericardium, dura mater and cornea are available as a
patch graft. Drawbacks of some of these materials may include high cost and poor appearance. The purpose of this
study is to report the long-term outcomes of partial thickness corneal grafts to cover the tube and prevent its
exposure, in GDD surgeries.
Methods: This was a retrospective review of all patients who underwent Ahmed glaucoma valve implantation and
had a minimum follow-up of 12 months. The tube was covered by a 300-micron partial thickness corneal graft
taken either from a previous Descemet stripping endothelial keratoplasty procedure or cut from a whole corneal
graft button unsuitable for keratoplasty.
Results: Forty-four patients (45 eyes, mean follow-up of 27.6 ± 11.4 months) were enrolled. The partial thickness
corneal grafts maintained clarity throughout follow-up with satisfactory cosmetic results. Mild conjunctival retraction
occurred in 4 eyes (8.9 %) between 1 and 12 months after the surgery. Corneal graft melting occurred in 3 (6.7 %)
eyes. Tube exposure and additional surgery to re-patch or suture the conjunctiva over the tube was needed in 1
(2.2 %) eye. None of the patients had graft infection or immunologic rejection.
Conclusions: Partial thickness corneal grafts have favorable long-term outcome as a patch for GDD tubes with low
rates of tube exposure and other complications.
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Background
Glaucoma drainage device (GDD) surgeries are tradition-
ally performed after failed trabeculectomy or in cases
where trabeculectomy is at high risk for failure, such as in
the management of complex glaucomas [1]. The more
commonly used GDDs in current practice are the Ahmed,
Baerveldt and Molteno implants [1]. A GDD is composed
of a plate and a tube running along the sclera into the
anterior chamber. To protect it from erosion, the tube is
covered by a biologic tissue which is roofed by the con-
junctiva. A GDD is, however, a foreign device that is
implanted onto and into the eye and therefore bears surgi-
cal complications associated with foreign objects, among
them conjunctival erosion that results in plate or tube
exposure, diplopia and inflammation [2]. Covering the
tube with a patch graft is intended to prevent the conjunc-
tival erosion and the consequent tube exposure that put
the eye under the risk of late endophthalmitis [3]. Sclera,
pericardium, dura mater and cornea are available as a
patch graft [4], but there are few reports that compare
them [5, 6]. The use of a patch graft has some drawbacks,
such as cost [7] and the fact that it is a foreign body with
the potential to erode the overlying conjunctiva [7]. Spe-
cifically, the disadvantage of the scleral patch graft is its
thickness [5], which may be a cosmetic issue. On the other
hand, a pericardium patch might be too thin and a dura
matter patch is expensive [5]. These shortcomings have
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led some investigators to seek other solutions which do
not use patch grafts in GDD surgeries, but rather use a
scleral tunnel for the tube [7, 8]. Using partial thickness
corneal patch graft may resolve some of the above con-
cerns. The purpose of this study was to report the long-
term outcomes and complications of employing a partial




Demographic and perioperative data were collected
through a retrospective record review of all patients who
underwent GDD surgery with partial thickness corneal
graft covering between 2007 and 2011 at the Tel Aviv
Sourasky Medical Center. Inclusion criteria were age
above 18 years at the time of surgery and a minimum
follow-up of 12 months. Patients were excluded if they
had undergone a previous GDD surgery or if they had a
past or current ocular surface disease that could affect
the healing of the covering conjunctiva. Patients who
had concomitant surgeries, such as pars plana vitrec-
tomy or cataract surgery, were also excluded.
Corneas were obtained from the Tel Aviv Sourasky
Medical Center Lions Eye Bank after being approved for
transplantation. Corneas were stored in Eusol-C Corneal
Storage Media (AL.CHI.MI.A.SRL, Padova, Italy). Tissue
evaluation included serology for hepatitis B and C, as
well as for HIV. All surgeries were performed by one
surgeon (RR) who was also responsible for the clinic
visits that included intraocular pressure (IOP) measure-
ments with Goldmann applanation tonometry (AT 900,
Haag-Streit AG, Koeniz, Switzerland) before and period-
ically after surgery. The study followed the tenets of the
Declaration of Helsinki and was approved by the ethics
committee of the Tel-Aviv Sourasky Medical Center.
Surgical technique
All GDDs were implanted through a fornix-based inci-
sion using the FP7 Ahmed glaucoma valve (New World
Medical, Inc., Rancho Cucamonga, CA), with the plate
secured 8–12 mm from the corneoscleral limbus.
Thirty-three eyes (73.3 %) underwent superotemporal
GDD implantation, 11 eyes (24.4 %) underwent infero-
temporal implantation, and 1 eye (2.2 %) underwent
inferonasal implantation.
After priming, the tube was inserted through a scleral
track posterior to the limbus by a 23-gauge needle, and
introduced by an inserter into the anterior chamber.
Viscoelastic was injected into the anterior chamber to
maintain its proper depth. The partial thickness corneal
graft, which was used to cover the tube, was sutured to
the sclera with four 10-0 nylon sutures. The conjunctiva
was closed meticulously with 8-0 vicryl and 10-0 nylon
sutures, taking care to ensure that it fully covered the
corneal graft.
A partial thickness corneal graft was taken either from
a previous Descemet stripping endothelial keratoplasty
(DSEK) procedure or cut from a whole corneal graft but-
ton. Corneal grafts prepared for a DSEK procedure were
cut by an automated microkeratome system (Moria
ALTK System, Antony, France) with a 300 micron head
passed to create a lamellar dissection. This formed an
anterior cap mainly composed of stroma and a posterior
endothelial lamellar donor graft. The posterior corneal
lamella was used for the DSEK procedure, while the
anterior corneal lamella was either discarded or used to
cover the tube in the GDD surgery of a different patient.
In other cases, a partial thickness corneal graft was
prepared from a full-thickness corneal graft that was un-
suitable for keratoplasty (i.e., donor age >80 years, low
graft clarity, endothelial cell count <2000 cells/mm2 and
expired tissue [7–60 days from harvesting]).
Statistical analysis
All the data were recorded on Microsoft Excel™ spread-
sheets. A paired-samples t-test was used to compare
mean pre- and postoperative IOPs. Bonferroni correc-
tion for multiple comparisons and a mixed model for
repeated measures were also used. Analyses were two-
tailed, and significance was set at the 5 % level. Statis-
tical analysis was performed with SPSS™ software V.21
(SPSS, Inc., Chicago, IL).
Results
Forty-four patients (45 eyes), comprised of 25 males and 19
females with a mean postoperative follow-up of 27.6 ±
11.4 months (range 12–60 months) fulfilled the inclusion
criteria and were included in the analysis. Their demo-
graphic characteristics and clinical data are summarized in
Table 1. The glaucoma subtypes of the study population are
summarized in Table 2. The postoperative IOP levels at the
different follow-ups were consistently lower (P < 0.001)
than the preoperative IOP values (Table 1). These differ-
ences remained significant after Bonferroni correction for
multiple comparisons and application of a mixed model for
repeated measures. The mean IOP reduction (i.e., the last
recorded preoperative IOP compared to the last recorded
postoperative IOP) was 50 %. The mean number of topical
anti-glaucoma medications decreased from 3.0 ± 0.9
(range 1–4) to 1.3 ± 1.2 (range 0–4) on the last postopera-
tive follow-up.
Thirty-three (73.3 %) partial thickness corneal grafts
were retrieved from previous DSEK procedures and 12
grafts (26.7 %) were prepared during the GDD surgery
from full corneal grafts that were unsuitable to serve as an
optical corneal graft. The mean corneal patch diameter
was 8.3 ± 0.2 mm (range 8.0–.0 mm). The conjunctiva that
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covered the corneal patch graft had a button hole during
surgery in 1 case (2.2 %). The conjunctival edges were
approximated by 8-0 vicryl sutures. There were no other
intra-operative complications.
None of the patients had graft infection or immuno-
logic rejection and the partial thickness corneal grafts
maintained clarity throughout follow-up. There were no
GDD-related complications, such as diplopia, inflamma-
tory reaction in the conjunctiva or plate exposure. Four
eyes (8.9 %) had conjunctival retraction between 1 and
12 months after the surgery. As the conjunctival retraction
was minimal, Seidel test was negative, and the tube was
well-covered by the patch graft, these patients were ob-
served without treatment. Conjunctival erosion with tube
exposure occurred in 1 case (2.2 %) with superotemporal
GDDs. In this patient the corneal patch graft was also
melting 1 month after surgery (Table 3). The patient
underwent re-patching with another corneal graft and
conjunctival closure. Three eyes (6.7 %) had corneal graft
melting (Table 3): in one of them it occurred with con-
junctival erosion and tube exposure as was described. In
the other 2 patients graft melting occurred 12 and
33 months postoperatively. As the overlying conjunctiva
was intact they were observed expectantly without the
need for surgical intervention.
Discussion
Partial thickness corneal patch grafts covering GDD
tubes have favorable long-term outcomes. According to
our results, these grafts are associated with a 6.7 % rate
of corneal graft melting and a 2.2 % rate of tube expos-
ure. Only one case necessitated additional surgery to
cover the exposed tube. A GDD transports aqueous
humor from the eye through a tube to an episcleral plate
located in one of the quadrants of the globe. The aque-
ous diffuses through the capsular wall and is absorbed
by periocular lymphatics and capillaries [3, 9]. Post-
surgical complications unique to GDDs include tube-
endothelial contact which may cause significant corneal
endothelial damage, fibrous encapsulation leading to
filtration failure, continuing low-grade inflammation,
and tube or plate migration or extrusion [2].
Conjunctival retraction leading to patch graft exposure
is usually considered a minor complication, as long as
the tube is well covered by the patch graft [10]. This
condition, which does not require surgical intervention,
was previously found in 33.5 % of eyes undergoing GDD
implantation [10], compared with 8.9 % in the current
study. Nevertheless, if the conjunctival retraction is sig-
nificant and the tube is exposed, this may place the eye
at risk for infection, especially if Seidel test is positive.
Repairing the exposure in these cases may be challen-
ging, especially if the conjunctiva is scarred.
Direct contact between the conjunctiva and the tube
will cause the tube to erode the overlying conjunctiva
over time and become exposed [7], putting the eye at
risk of infection and endophthalmitis [3]. The most vul-
nerable site for tube erosion is at its entrance through
the sclera, and the role of the patch graft is to prevent
tube erosion [3]. Although this approach has been
shown to decrease exposure rates, it does not always
prevent this complication [7]. The reported rates for
tube exposure or device extrusion range between 3 and
30.5 % [7, 10–13], putting our 2.2 % rate at the bottom
of the scale. In the event of tube or plate exposure, the
condition of the conjunctiva and patch graft needs to be
assessed. The majority of those cases are effectively
managed by conjunctival suturing with patch grafting,
while poor conjunctiva quality may necessitate the use
Table 1 Demographic and clinical data of 44 patients (45 eyes)
who underwent glaucoma drainage device surgery
Male/female (%) 56.8/43.2
Age (years) 71.0 ± 10.8
(range 34–92)
Preop.duration of glaucoma (months) 116.2 ± 105.8
(range 1–396)
Trabeculectomies before surgery (n) 0.9 ± 0.9
(range 0–4)
Right/left eye (%) 55.6/44.4
Mean intraocular pressure (mmHg)
Preoperative 30.1 ± 8.1
Postop. day 1 10.9 ± 5.4*
Postop. week 1 10.5 ± 5.2*
Postop. month 1 12.7 ± 5.8*
Postop. month 3 14.1 ± 6.4*
Postop. month 6 13.3 ± 5.3*
Postop. year 1 13.8 ± 4.9*
Postop. year 2 12.8 ± 3.6*
Postop. final visit 14.5 ± 4.9*
Postop postoperative
*P < 0.001 (compared to preoperative)
Table 2 Subtype of glaucoma in 44 patients (45 eyes) who
underwent glaucoma drainage device surgery
Subtype n (%)
Pseudoexfoliation glaucoma 11 (25.5)
Open angle glaucoma 9 (20.5)
Neovascular glaucoma 9 (20.5)
Post penetrating keratoplasty glaucoma 6 (13.6)
Uveitic glaucoma 4 (9.1)
Chronic angle closure glaucoma 2 (4.5)
Malignant glaucoma 1 (2.3)
Angle recession 1 (2.3)
Normal tension glaucoma 1 (2.3)
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of a conjunctival auto-graft, amniotic membrane or buccal
graft [14, 15]. Re-patching with a different material should
be considered in the event that the patch graft has melted
[16]. However, removal of the plate or tube may neverthe-
less be necessary [13] as had been the case in one of our
subjects. Causes for tube exposure have not been clearly
elucidated in the literature [17], and the reported risk fac-
tors are inconsistent. Potential risk might be related to
conjunctival status (as affected by aging, inflammation,
and device mobility) [18], the number of previous ocular
surgeries [18], the number of preoperative hypotensive
medications [10], and a previous trabeculectomy [17].
Inferior quadrant implantation bears a higher risk of
conjunctival erosion over the plate, possibly because of ex-
posure or a shallower space within the inferior fornix and
less conjunctiva and Tenon’s capsule for implant coverage
[10, 19, 20]. Another report suggested that tube exposure
does not differ between Ahmed, Baerveldt, and Molteno
implants [21]. However, since that report included 38
studies with many surgeons using different surgical tech-
niques and different patch grafts, it is difficult to arrive at
any firm conclusion from those data. The low rate of com-
plications relevant to the conjunctiva and the partial thick-
ness corneal graft in the current study makes it impossible
for us to draw conclusions about the risk factors for graft
patch melting and tube exposure. Two out of the 3 cases
with melting had the implant placed inferiorly. Also, an
immune-mediated process with resultant rapid melting
may have contributed to the corneal melting in one of our
patients who had underlying uveitis.
Considerations in the choice of patch graft material
include biocompatibility, availability, immunologic safety,
ease of use, cost and cosmetic appearance [22]. The use of
allograft materials, among which the most common are
sclera, pericardium, dura mater and cornea, has some dis-
advantages. Insofar as they are foreign bodies, they have a
prima facie potential to erode the overlying conjunctiva
[7]. Secondly, they involve considerable cost [7]. The main
disadvantage of preserved sclera is its thickness [5], which
may be an issue of cosmetic appearance. Sterility and vari-
able quality are other concerns [5]. When an autologous
scleral patch graft is used, large areas of sclera may be
thinned for harvesting the graft, thus carrying the risk of
perforation as well [22]. As for a pericardium graft, it may
be a priori too thin and also prone to more melting with
longer follow-up [5]. Both pericardium and dura matter
are expensive [5]. The use of gamma-irradiated cornea
(VisionGraft) for the coverage of a glaucoma tube shunt
was recently described as allowing for both decreased risk
of disease transmission and improved availability [22].
However, prions are still a risk in these corneas and the
high cost is a major obstacle. These drawbacks have led
some investigators to seek other solutions, such as placing
the tube in a scleral tunnel [8] with or without Tenon
advancement and a conjunctival–Tenon flap [7]. These
descriptions, however, are all derived from anecdotal re-
ports and the conventional surgical method continues to
be the use of a patch graft in GDD surgeries.
The biologic material used as a patch graft in GDD
surgeries has at least some role in preventing tube ero-
sion [6], but discussions of these issues are sparse. One
report [5] stated that no material was more prone to
erosion or melting than another when comparing donor
sclera, dura mater and pericardium. Those authors, how-
ever, reported a high incidence of donor patch graft
thinning (22–26 %) for all 3 of those materials. A corneal
patch graft may have some advantages over other cover-
ing materials. Its tissue strength and rigidity make it par-
ticularly suitable for tectonic support of the ocular wall,
and it may be less prone to melting compared to other
patch grafts [4, 22, 23]. Moreover, its translucency gives
the patient’s eye a better cosmetic appearance [23],
Table 3 Description of 3 patients with partial thickness corneal patch graft melting
Characteristics Patient 1 Patient 2 Patient 3
Gender Male Female Male
Age (years) 74 66 79
Eye Left Right Left
Type of glaucoma Pseudo-exfoliation Uveitic glaucoma Pseudo-exfoliation
IOP before surgery (mmHg) 25 25 24
Trabeculectomies before surgery (n) 4 1 1
Location of Ahmed valve Inferotemporal Inferotemporal Superotemporal
Medications before/after the surgery (n) 4/4 3/2 4/0
Corneal patch graft diameter (mm) 8.5 8.25 8.5
Complications during surgery None None None
Post-surgery melting (months) 33 12 1
Follow-up duration (months) 42 36 32
IOP, intraocular pressure
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which is most relevant in cases where the GDD is placed
in the inferior quadrants [22]. Migration, retraction and
twisting are possible complications of the tube [24, 25],
and they may be difficult to diagnose under an opaque
patch graft, such as sclera or pericardium. The translu-
cency of the cornea allows direct visualization of the
underlying tube and greater facility in the diagnosis of
possible complications [4]. It also facilitates laser suture
lysis of the tying suture with non-valved tubes. We be-
lieve that the use of a partial thickness corneal graft
offers satisfactory tectonic support and has some add-
itional benefits over full thickness corneal grafts. The
thin patch we use occupies little of the narrow space of
the conjunctiva-sclera, thus minimizing the likelihood of
the patch graft to erode the overlying conjunctiva. Indeed,
none of our patients had that complication. The thin
patch may also reduce the postoperative risk of dellen for-
mation. Finally, the partial thickness corneal graft can be
taken from a previous DSEK procedure or from a corneal
graft that is unsuitable for optic corneal transplantation.
This increases the availability of banked tissue without
additional costs.
While a patch graft must be completely covered by the
conjunctiva during the surgery, conjunctival laceration or
button-hole formation may occur [10]. Simple suturing of
the conjunctiva must then be carried out to ensure that
the patch graft, tube and plate are entirely covered. This
intra-operative complication occurred in one of our cases
and was successfully dealt by prompt re-approximation of
the conjunctival edges.
Limitations of this study include its retrospective nature,
the relative small sample size and the lack of a control
group with which to compare our results. Prospective
randomized studies comparing partial thickness cornea to
other patch graft materials are needed in order to deter-
mine which patch is less prone to conjunctival erosion
and subsequent tube exposure. Cost considerations,
the ideal thickness of the patch graft and its cosmetic
appearance should also be taken into consideration.
Since our analysis included only patients with follow-
up of ≥12 months, complications occurring in patients
with shorter follow-up were not reported, and this could
have been a confounding factor. Although the mean post-
operative follow-up time was more than 2 years, it was
only 12 months in four patients. It is not clear whether a
longer follow-up would reveal more cases of conjunctival
dehiscence or corneal graft melting, but we consider it
most probable that more of them would emerge over
time. Some authors argued that these complications usu-
ally occur within the first 15-month postoperative period
[5], while others held that these complications may occur
even after 5 years [21]. Graft melting occurred 33 months
after surgery in one of our patients, which suggests that
patients who underwent GDD surgery should be
examined regularly for years after surgery. The strict ex-
clusion criteria that eliminated any cases of previous GDD
surgery and patients with past and current ocular surface
disease represent a strength of our study by allowing the
evaluation of the partial thickness cornea as a patch graft
without confounding factors that may influence conjunc-
tival healing or erosion. Another strength is that all
surgeries were done by one surgeon using the same tech-
nique, unlike most studies that evaluated the results and
complications of GDDs placed by different surgeons using
different techniques. Indeed, variations in techniques
might affect tube exposure [6], making it difficult to draw
any conclusions about the effectiveness of a specific patch
graft in preventing the silicone tube exposure. We used a
corneal patch that had an 8–9 mm diameter. The optimal
size of a patch graft that will cover the tube completely
from limbus to the plate has not yet been established, and
this issue warrants further study.
Conclusions
A partial thickness corneal graft is a useful patch graft ma-
terial for covering a GDD. It is associated with low rates
of conjunctival retraction, graft melting, tube exposure
and need for additional surgery.
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